DOACs vs warfarin: Rethinking anticoagulation strategies for portal vein thrombosis prophylaxis in patients with increased risk.. If you have the appropriate software installed, you can download ...

Many patients with the antiphospholipid antibody syndrome and recurrent thrombosis receive doses of warfarin adjusted to achieve an international normalized ratio (INR) of more than 3.0. However, t ...

A model can predict the risk for portal vein thrombosis in patients on the waiting list for liver transplantation, a large database study shows, but whether prophylaxis can help has to be determined.

In six studies comparing low-molecular-weight heparin with warfarin after total knee replacement, the rates of venographically identified deep- vein thrombosis in the groups that received low ...

“The elevation in INR can be explained by the inhibition of CYP2C9 by cannabis use causing decreased metabolism of warfarin,” the authors explained.

Children with cavernous transformation of the portal vein can develop bleeding from portal hypertension during childhood or early adulthood. [19] Encephalopathy in chronic PVT is uncommon.

Portal vein thrombosis (PVT) is a blood clot that causes irregular blood flow to the liver. Learn about the symptoms and treatment of this condition.

The review of COVID-19–related portal vein thrombosis cases, apart from a few with a fatal outcome, or gastrointestinal bleeding, or bowel ischemia,2 shows that usually anticoagulation treatment ...

The genetics-informatics trial (GIFT) of warfarin to prevent deep vein thrombosis (DVT) is a 2 × 2 factorial-design, randomized controlled trial designed to compare the safety and effectiveness ...

“Extended INR testing for stable warfarin patients can be successfully and safely implemented in diverse, practice-based anticoagulation clinic settings,” the authors write.

In patients with cerebral venous thrombosis, direct oral anticoagulants were safer than warfarin without compromising efficacy, researchers reported at the International Stroke Conference.

In the same year, Russell Hull and colleagues published a randomized study comparing patients with proximal vein thrombosis treated with a dose of warfarin adjusted according to a PT reagent made ...